Details for New Drug Application (NDA): 062298
✉ Email this page to a colleague
The generic ingredient in ERY-TAB is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062298
Tradename: | ERY-TAB |
Applicant: | Azurity |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 062298
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 062298
Suppliers and Packaging for NDA: 062298
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298 | ANDA | Arbor Pharmaceuticals, Inc. | 24338-122 | 24338-122-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-03) |
ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298 | ANDA | Arbor Pharmaceuticals, Inc. | 24338-122 | 24338-122-13 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-13) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 250MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 333MG | ||||
Approval Date: | Mar 29, 1982 | TE: | AB | RLD: | No |
Complete Access Available with Subscription